相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A review of lipidation in the development of advanced protein and peptide therapeutics
Romel Menacho-Melgar et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Design and Synthesis of Potent, Long-Acting Lipidated Relaxin-2 Analogs
Avinash Muppidi et al.
BIOCONJUGATE CHEMISTRY (2019)
Challenges in the design of insulin and relaxin/insulin-like peptide mimetics
Mohammed Akhter Hossain et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
BeStSel: a web server for accurate protein secondary structure prediction and fold recognition from the circular dichroism spectra
Andras Micsonai et al.
NUCLEIC ACIDS RESEARCH (2018)
Chemical Strategies for Half-Life Extension of Biopharmaceuticals: Lipidation and Its Alternatives
Esben M. Bech et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
The actions of relaxin on the human cardiovascular system
Mohsin Sarwar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
B7-33 replicates the vasoprotective functions of human relaxin-2 (serelaxin)
Sarah A. Marshall et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Human Relaxin Receptor Is Fully Functional in Humanized Mice and Is Activated by Small Molecule Agonist ML290
Elena M. Kaftanovskaya et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2017)
The molecular basis for the prolonged blood circulation of lipidated incretin peptides: Peptide oligomerization or binding to serum albumin?
Ying Wang et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Development of a Single-Chain Peptide Agonist of the Relaxin-3 Receptor Using Hydrocarbon Stapling
Keiko Hojo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
The complex binding mode of the peptide hormone H2 relaxin to its receptor RXFP1
Ashish Sethi et al.
NATURE COMMUNICATIONS (2016)
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
Jesper Lau et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
International Union of Basic and Clinical Pharmacology. XCV. Recent Advances in the Understanding of the Pharmacology and Biological Roles of Relaxin Family Peptide Receptors 1-4, the Receptors for Relaxin Family Peptides
Michelle L. Halls et al.
PHARMACOLOGICAL REVIEWS (2015)
Synthetic relaxins
Mohammed Akhter Hossain et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2014)
Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial
Gerasimos Filippatos et al.
EUROPEAN HEART JOURNAL (2014)
The design and discovery of lixisenatide for the treatment of type 2 diabetes mellitus
Mikkel Christensen et al.
EXPERT OPINION ON DRUG DISCOVERY (2014)
The emerging role of relaxin as a novel therapeutic pathway in the treatment of chronic kidney disease
Jennifer M. Sasser
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2013)
Minimum Active Structure of Insulin-like Peptide 5
Alessia Begi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Peptide lipidation stabilizes structure to enhance biological function
Brian P. Ward et al.
MOLECULAR METABOLISM (2013)
The Different Ligand-Binding Modes of Relaxin Family Peptide Receptors RXFP1 and RXFP2
Daniel J. Scott et al.
MOLECULAR ENDOCRINOLOGY (2012)
Effects of Relaxin on Arterial Dilation, Remodeling, and Mechanical Properties
Kirk P. Conrad et al.
CURRENT HYPERTENSION REPORTS (2011)
Design, Synthesis, and Characterization of a Single-Chain Peptide Antagonist for the Relaxin-3 Receptor RXFP3
Linda M. Haugaard-Kedstrom et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Structure-activity and protraction relationship of long-acting glucagon-like peptide-1 derivatives: Importance of fatty acid length, polarity, and bulkiness
Kjeld Madsen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Conformationally constrained single-chain peptide mimics of relaxin B-chain secondary structure
MP Del Borgo et al.
JOURNAL OF PEPTIDE SCIENCE (2005)
Time course and dose response of relaxin-mediated renal vasodilation, hyperfiltration, and changes in plasma osmolality in conscious rats
LA Danielson et al.
JOURNAL OF APPLIED PHYSIOLOGY (2003)